Companies / Comera Life Sciences Holdings, Inc.
Comera Life Sciences Holdings, Inc.
CMRACIK 1907685
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Sep 11, 2023 | Cherington Charles 10% owner | Buy Open-market buy | Common Stock | $1.05M | +2.1M +54.62% | 5,813,650 | high |
| Jan 4, 2023 | Cherington Charles 10% owner | Buy Open-market buy | Common Stock | $914.2K | +743K +34.79% | 2,879,666 | high |
| Jul 31, 2023 | Cherington Charles 10% owner | Buy Open-market buy | Common Stock | $450.0K | +880K +30.57% | 3,759,861 | medium |
| Sep 12, 2022 | Sherblom James Director | Buy Open-market buy | Common Stock | $101.5K | +50K +15.57% | 371,163 | medium |
| Jan 4, 2023 | Sherblom James Director | Buy Open-market buy | Common Stock | $99.7K | +81K +21.85% | 452,244 | medium |
| Jan 4, 2023 | Sherblom James Director | Grant Grant or award | Common Stock | $99.7K | +81K +21.85% | 452,244 | low |
| Sep 9, 2022 | Hackman Jeffrey S. Executive | Buy Open-market buy | Common Stock | $98.1K | +48K | 47,600 | medium |
| Jan 4, 2023 | Soane David 10% owner | Buy Open-market buy | Common Stock | $83.1K | +68K +319.28% | 88,729 | medium |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| CMRA | common | 20037C108 |